West Pharmaceutical Services Inc (WST) insider trading
Every open-market stock purchase and sale by West Pharmaceutical Services Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Annette F Favorite (C-suite exec) sold $5.4M in the last 90 days.
- Last insider buy: Patrick J Zenner (Insider), $5.7K, 7 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $6.6M (4 sales). Last close $366.60 on Sep 17, 2026.
Recent WST insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Annette F Favorite (C-suite exec) | Sold | $921K |
| Sep 15, 2026 | Annette F Favorite (C-suite exec) | Bought (not open market) | — |
| Sep 14, 2026 | Annette F Favorite (C-suite exec) | Sold | $888K |
| Sep 14, 2026 | Annette F Favorite (C-suite exec) | Bought (not open market) | — |
| Sep 11, 2026 | Annette F Favorite (C-suite exec) | Sold | $863K |
| Sep 11, 2026 | Annette F Favorite (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Annette F Favorite (C-suite exec) | Sold | $960K |
| Sep 8, 2026 | Annette F Favorite (C-suite exec) | Sold | $960K |
| Sep 8, 2026 | Annette F Favorite (C-suite exec) | Sold | $852K |
| Sep 8, 2026 | Michel Lagarde (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Michel Lagarde (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Michel Lagarde (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Michel Lagarde (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Michel Lagarde (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Michel Lagarde (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Annette F Favorite (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Annette F Favorite (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Annette F Favorite (C-suite exec) | Bought (not open market) | — |
| Aug 11, 2026 | Robert W. McMahon (CFO) | Sold (not open market) | $971K |
| Aug 11, 2026 | Robert W. McMahon (CFO) | Sold (not open market) | $121K |
| Aug 11, 2026 | Robert W. McMahon (CFO) | Bought (not open market) | — |
| Aug 11, 2026 | Robert W. McMahon (CFO) | Bought (not open market) | — |
| May 12, 2026 | Shane Alden Campbell (VP) | Sold (not open market) | $42.1K |
| May 12, 2026 | Shane Alden Campbell (VP) | Sold (not open market) | $26.3K |
| May 12, 2026 | Shane Alden Campbell (VP) | Bought (not open market) | — |
Who's trading WST
- Annette F Favorite, C-suite exec: sold $6.3M (7 sales), last Sep 15, 2026
- Michel Lagarde, CEO: other filings, last Sep 8, 2026
- Robert W. McMahon, CFO: other filings, last Aug 11, 2026
- Shane Alden Campbell, VP: other filings, last May 12, 2026
- Stephen H Lockhart, Director: other filings, last May 4, 2026
- Mark A Buthman, Director: other filings, last May 4, 2026
- Robert F Friel, Director: other filings, last May 4, 2026
- William F Feehery, Director: other filings, last May 4, 2026
- Molly Joseph, Director: other filings, last May 4, 2026
- Deborah L Keller, Director: other filings, last May 4, 2026
- Goldman Myla Lai, Director: other filings, last May 4, 2026
- Douglas A Michels, Director: other filings, last May 4, 2026
- Janet Brutschea Haugen, Director: other filings, last May 4, 2026
- Paolo Pucci, Director: other filings, last May 4, 2026
- Chad Winters, C-suite exec: sold $269K (1 sale), last Apr 27, 2026
Get free alerts when an insider at West Pharmaceutical Services Inc files a new trade →